日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants.

针对刺突蛋白 NTD 的广谱中和单域抗体对多种 SARS-CoV-2 变种显示出治疗效果。

Korobkova Anastasia I, Favorskaya Irina A, Shuliakova Inna V, Iliukhina Anna A, Grousova Daria M, Alekseeva Irina A, Ryabova Ekaterina I, Derkaev Artem A, Azizyan Valentin V, Zorkov Ilya D, Dzharullaeva Alina S, Tukhvatulin Amir I, Esmagambetov Ilias B, Prokofiev Vladimir V, Voronina Daria V, Zubkova Olga V, Shcheblyakov Dmitry V, Logunov Denis Y

Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus

针对甲型流感病毒 H3 血凝素的广谱纳米抗体

D V Shcheblyakov, D V Voronina, I A Favorskaya, I B Esmagambetov, I A Alekseeva, A I Korobkova, E I Ryabova, A A Derkaev, V Yu Kan, A Sh Dzharullaeva, A I Tukhvatulin, A S Bandelyuk, M M Shmarov, D Yu Logunov, A L Gintsburg

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

用于COVID-19紧急预防和长期预防的表达重组抗体的rAAV

Esmagambetov, Ilias B; Ryabova, Ekaterina I; Derkaev, Artem A; Shcheblyakov, Dmitry V; Dolzhikova, Inna V; Favorskaya, Irina A; Grousova, Daria M; Dovgiy, Mikhail A; Prokofiev, Vladimir V; Gosudarev, Andrey I; Byrikhina, Daria V; Zorkov, Ilia D; Iliukhina, Anna A; Kovyrshina, Anna V; Shelkov, Artem Y; Naroditsky, Boris S; Logunov, Denis Y; Gintsburg, Alexander L

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A

使用 mRNA 平台进行单域抗体递送可抵御致死剂量的 A 型肉毒杆菌毒素

Eugenia A Panova, Denis A Kleymenov, Dmitry V Shcheblyakov, Evgeniia N Bykonia, Elena P Mazunina, Alina S Dzharullaeva, Anastasia N Zolotar, Artem A Derkaev, Ilias B Esmagambetov, Ivan I Sorokin, Evgeny V Usachev, Anatoly N Noskov, Igor A Ivanov, Timofei S Zatsepin, Sergey E Dmitriev, Vladimir A Gus

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

单域抗体可有效中和令人担忧的 SARS-CoV-2 变体

Irina A Favorskaya, Dmitry V Shcheblyakov, Ilias B Esmagambetov, Inna V Dolzhikova, Irina A Alekseeva, Anastasia I Korobkova, Daria V Voronina, Ekaterina I Ryabova, Artem A Derkaev, Anna V Kovyrshina, Anna A Iliukhina, Andrey G Botikov, Olga L Voronina, Daria A Egorova, Olga V Zubkova, Natalia N Ryz

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis

表达重组中和抗体的 rAAV,用于预防 A 型肉毒杆菌毒素

Artem A Derkaev, Ekaterina I Ryabova, Ilias B Esmagambetov, Dmitry V Shcheblyakov, Svetlana A Godakova, Irina D Vinogradova, Anatoly N Noskov, Denis Y Logunov, Boris S Naroditsky, Alexander L Gintsburg

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses

针对甲型流感病毒血凝素主干结构域的中和纳米抗体的开发

D V Voronina, D V Shcheblyakov, I B Esmagambetov, A A Derkaev, O Popova, D N Shcherbinin

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection

纳米抗体是治疗埃博拉病毒感染的潜在药物

I B Esmagambetov, D V Shcheblyakov, D A Egorova, O L Voronina, A A Derkaev, D V Voronina, O Popova, E I Ryabova, D N Shcherbinin, E I Aksenova, A N Semenov, M S Kunda, N N Ryzhova, O V Zubkova, A I Tukhvatulin, D Yu Logunov, B S Naroditsky, S V Borisevich, A L Gintsburg